English version

VI Międzynarodowa Konferencja Bioetyczna "Etyczne aspekty badań podstawowych i klinicznych" 3-4 czerwca 2005, Warszawa

• Miejsce obrad Konferencji
  
  Międzynarodowe Centrum Biocybernetyki
  Ul. K. Trojdena 4
  02-109 Warszawa
  
  
• Komitet Naukowy Konferencji
  
  Ks. Prof. W. Bołoz
  Prof. A. Górski (przewodniczący)
  Prof. M.W. Grabski
  Prof. T. Tołłoczko
  
  Kontakt: agorski@ikp.pl
  
  

Konferencja organizowana pod patronatem Ministra Nauki, Ministra Zdrowia i Wydziału Nauk Medycznych PAN we współpracy z Urzędem ds. Rzetelności Badań Naukowych, USA
oraz Stowarzyszeniem Przedstawicieli Firm Farmaceutycznych w Polsce



• Sekretariat Konferencji
  
  “CONGRESS-OR”
  Biuro Kongresów i Turystyki
  Ul. Żurawia 47 lok. 304
  00-680 Warszawa
  tel. / fax. (+ 48 22) 621-31-16; 628 45 48
  e-mail: d.korpaczewska@congressor.com.pl
  
  




PROGRAM

W celu obejrzenia prezentacji, proszę "kliknąć" na tytuł referatu.

Wszelkie prawa autorów prezentacji zastrzeżone. Każdy, kto używa prezentacji, powinien podać autora i instytucję, z jakiej ona pochodzi.


June 3, 2005


9:00	Opening ceremony
SESSION I (Chairs: Pieter Drenth, All European Academies, The Netherlands; Eero Vuorio, Finnish Natl. Advisory Board on Res. Ethics)
9:30 – 10:00	What Constitutes Responsible Conduct of Research, Nicholas Steneck, Office of Research Integrity; University of Michigan, USA
10:00 – 10:30	Scientific Integrity and The Role of Academies of Science, Pieter Drenth, President, All European Academies, The Netherlands
10:30 – 11:00	Authorship and Publication Practices, Michael J.G. Farthing, St George’s Hospital Medical School, Univ of London, UK
11:00 – 11:20	Discussion
11:20 – 11:30	Break
11:30 – 12:00	Data Management, Chris Pascal, Office of Research Integrity, USA
12:00 – 12:30	Discussion
12:30 – 13:30	Lunch
SESSION II (Chairs: Zbigniew Szawarski, University of Warsaw, PL; Eugenijus Gefenas, Medical Faculty, University of Vilnius, LT)
13:30 – 14:00	Towards Greater Transparency of Clinical Research - An IFPMA Perspective, Maciej Gajewski, International Association of Pharmaceutical Manufacturers & Associations, Geneva, CH
14:00 – 14:30	Peer Review, David Wright, Michigan State Univ
14:30 – 15:00	Discussion
15:00 – 15:15	Break
15:15 – 16:00	Collaborative Research, Howard Gadlin, Ombudsman, National Institutes of Health, USA
16:00 – 16:45	Discussion
16:45 – 17:30	The Handling of Research Misconduct Allegations, Chris Pascal, Office of Research Integrity, USA; Pitfalls in Clinical Research, Piotr Zaborowski, The Medical University of Warsaw, PL
17:30 – 18:00	Discussion



June 4, 2005


SESSION III (Chairs: Marie Charlotte Bouesseau, World Health Organization, Switzerland; Andrzej Górski, Committee on Ethics in Science, Ministry of Science/Bioethics Commission, Ministry of Health, PL)
9:00 – 9:45	Mentor – Trainee Relationships, David Wright, Michigan State University, USA; Mentor and Trainee in Clinical Academic Medicine, Tadeusz Tolloczko, Warsaw, PL
9:45 – 10:15	Discussion
10:15 – 10:45	Establishing a Responsible Conduct of Research Program, Nicholas Steneck, Office of Research Integrity; University of Michigan
10:45 – 11:05	Discussion
11:05 – 11:20	Break
11:20 – 11:50	Institutionalizing Ethics: The Mission, Function, and Responsibilities of Research Ethics Committees, Marie – Charlotte Bouesseau, Ethics, Trade, Human Rights and Health Law, World Health Organization, CH
11:50 – 12:10	Discussion
12:10 – 12:55	Protection of Animal Research Subjects, Czeslaw Radzikowski, International Council of Laboratory Animal Science, PL; Ethical and Welfare Aspects of Animal Experimentation, Roman Kolar, Deputy Director, Animal Welfare Academy, German Animal Welfare Federation, D; Human Rights vs. Animal Rights: How to Apply ‘Humane Treatment’ in Animal Research, Ioana Ispas, European Integration Councellor for Bioethics, Genomics and Health, Ministry of European Integration, Bucharest, RO
12:55 – 13:25	Discussion
13:25 – 14:30	Lunch
SESSION IV (Chairs: Melody Lin, US Department of Health; John Williams, World Medical Association)
14:30 - 15:45	Protection of human research subjects Research Protections and Research Enterprise – Melody Lin, US Dept of Health and Human Services; The Physician's Role in The Protection of Human Research Subjects – John Williams, World Medical Association, Geneva, CH; Biomedical Research, Globalization and The Commerce: The Need for Special Protection of The Poor – R.R.Kishore, President, Indian Society for Health, Laws, and Ethics, New Delhi, India
15:45 – 16:15	Discussion
16:15 – 16:30	Break
16:30 - 18:00	Communications (Chairs: Hans-Joerg Ehni, University of Tuebingen, Germany; Svetlana Pustovit, Kiev, Ukraine) The Definition of Adequate Care in Externally Sponsored Clinical Trials, Hans-Joerg Ehni, University of Tuebingen, Germany The Concept of Quality in Clinical Research, Dorota Switula, Senior CQA Advisor, AstraZeneca Global Clinical Quality Assurance, AstraZeneca Pharma, Poland Concept of Risk and Ethical Review of Biomedical Research, Eugenijus Gefenas, The Medical Faculty, University of Vilnius, Lithuania Evaluation of Drug Toxicity in Clinical Trials: a Biased Misconception, Jacek Splawinski, National Institute of Public Health, Poland Patient Safety in Clinical Research, Marek Labon, Director of Therapeutics, Academic Clinical Center, The Medical University of Gdansk, Poland Patient Protection in Clinical Trials, Marek Czarkowski, Bioethics Commission, Warsaw Chamber of Physicians, Poland Ethical Expertise in The Ukraine, Svetlana Pustovit, President, The Ukrainian Association on Bioethics, Kiev, Ukraine
18:00 – 18:30	Discussion
18:30	Summary and Conclusions, Ray Spier, Editor, Science & Engineering Ethics